Low-Intensity Focused Ultrasound (LIFU) for Non-Small Cell Lung Cancer Brain Metastases

Join Michael McDermott, M.D., chief medical executive of Baptist Health Miami Neuroscience Institute, and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience, along with Manmeet Ahluwalia, M.D., MBA, FASCO, the chief of medical oncology, chief scientific officer & deputy director, and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute, as they discuss a prospective clinical trial on the use of low intensity focused ultrasound for non-small cell lung cancer brain metastases, gender distribution, previous treatment results, and overall survival. Presenters Michael McDermott, M.D.Chief Medical Executive, Miami Neuroscience InstituteIrma & Kalman Bass Endowed Chair in Clinical Neuroscience Manmeet Ahluwalia, M.D., MBA, FASCOChief of Medical Oncology, Chief Scientific Officer & Deputy Director,Fernandez Family Endowed Chair in Cancer Research Baptist Health Miami Cancer Institute